RxDoctor Payments Data

Louis Krenn, MD

Family Medicine · Springfield, MONPI 1528071263

Payments from drug & device makers

$3,102in general payments, 2019–2025

Across 203 payments — averaging $15.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$561
  • AbbVie$386
  • Abbott$322
  • GSK$254
  • AstraZeneca$235
  • Boehringer Ingelheim$220
  • plus $1K from 17 others

What the payments were for

  • Speaking & faculty fees$1304%
  • Food & beverage$2,89793%
  • Education$752%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,102 in reported general payments places this provider in the 80th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$35,161
Medicare patients
190
Services billed
524

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban196$153,836
JardianceEmpagliflozin55$64,877
XareltoRivaroxaban59$61,751
TrulicityDulaglutide31$39,550
Spiriva RespimatTiotropium Bromide61$38,329
Stiolto RespimatTiotropium Br/Olodaterol Hcl47$34,139
OzempicSemaglutide28$26,723
Trelegy ElliptaFluticasone/Umeclidin/Vilanter31$26,700
Synjardy XrEmpagliflozin/Metformin Hcl38$24,633
JanuviaSitagliptin Phosphate13$15,053
Lantus SolostarInsulin Glargine,hum.Rec.Anlog65$12,025
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog13$11,209
Repatha SureclickEvolocumab17$10,358
TradjentaLinagliptin12$10,315
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog11$10,054

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Spiriva Respimat, Stiolto Respimat, Synjardy Xr, Tradjenta$220$172,292213 claims
PfizerEliquis$561$153,836196 claims
Johnson & JohnsonXarelto$59$61,75159 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Arexvy, Shingrix$254$53,536106 claims
Lilly USA, LLCTrulicity$38$39,55031 claims
Novo NordiskOzempic$73$26,72328 claims
MerckJanuvia$27$15,05313 claims
AstraZenecaSymbicort$235$8,34328 claims
AbbVieLinzess$386$5,93711 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Springfield

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →